News from the Anticoagulation Forum
December 2016
In this issue
Cancun Boot Camp * 14th National Conference * December Webinar * Grand Rounds  
Publishing Opportunities for Members *  Ottawa Blood Disease Centre Survey
NATF Support Groups * HTRS Fellow Awards
6th Regional AC Forum Bootcamp
Cancun, Mexico
 
January 26-27, 2017
Westin Resort & Spa, Cancun

Small-group learning, CE credit, expert faculty featured

AC Forum is partnering with Sociedad Mexicana de Trombosis y Hemostasia (SOMETH) to host its first international boot camp This compact 2-day meeting provides a comprehensive curriculum that covers the essential aspects of anticoagulation, disease state, and drug management. Engaging discussion around quality improvement, new agents and special situations will benefit all practitioners. Join practitioners from Mexico and abroad for daily international "chalk talks."

For more information and to register visit  acforumbootcamp.org.



Early-Registration Deadline Approaching
 for National Conference

December 15 Deadline for Discount Registration, Abstracts

December 15 is the deadline for early registration for LA17, our national conference in Los Angeles, CA, April 20-22, 2017. The 3-day symposium will bring together medical professionals in fields ranging from cardiology and hematology to pharmacy and family medicine for discussions on current research and evidence-based practices in the field of antithrombotic therapy.

Presentation topics include anticoagulation clinics in the future, DOACs in special populations, bridging updates, safe transitions of care, reversal agents, and more.

In addition to presentations by leading experts, the conference will feature small, topic-specific master classes,  a "meet the expert" breakfast, poster session and industry exhibits. The deadline for abstracts for the poster session -- including encore presentations, case studies and other research -- is also December 15.

Continuing education credit will be provided through the Postgraduate Institute of Medicine.

For more information and to register


Effectiveness and Safety of DOACs vs. Warfarin
in Non-valvular Atrial-Fibrillation
 
Wednesday, December 14
1:00 pm -- 2:00 pm (EST)
 
The emergence of DOACs has been a major advancement in the treatment of non-valvular AFib. But, are the outcomes seen in clinical trials happening in routine practice?
 
In this month's webinar, we'll look at a study comparing the effectiveness and safety of these treatments with each other and warfarin.
 
You can read the study here.
 
Speakers: Peter Noseworthy, MD, Mayo Clinic, Rochester MN
 Xiaoxi Yao, PhD, Mayo Clinic, Rochester MN
 
Moderators: 
Diane Wirth, ANP, Grady Memorial Hospital
Sara Vazquez, PharmD, University of Utah
 
 
AC Forum's Lunch & Learn Webinars are free and open to all healthcare professionals.

Grand Rounds Offered:
Anticoagulation and Reversal

Host Sites Wanted

The AC Forum, in collaboration with Boston University School of Medicine and IPRO, is offering free, CME/CE-certified in-hospital grand rounds presentations at medical facilities around the country.

"The ABC's of Anticoagulation and Reversal: Do you Know Your DOACs?" is a program designed to address questions surrounding handling bleeding complications in the changing landscape of anticoagulant therapies. The goal is to provide medical professionals with a comprehensive update and strategy for the reversal of oral anticoagulants in order to deliver the best possible care.

A minimum of 50 participants are required per host site. If you are interested in hosting this session at your hospital, please contact Elizabeth Drury, Program Manager at Boston University School of Medicine at edrury@bu.edu or 617-638-4605.

New Publishing Opportunities For AC Forum Members

The Anticoagulation Forum, in collaboration with the Journal of Thrombosis and Thrombolysis, is pleased to offer more publication opportunities for its community. Members are encouraged to submit original research and reviews within related areas of thrombosis, hemostasis, and vascular disease. Submissions will undergo an expedited peer-review process by the Journal's editorial team and, if accepted, will be featured in a special section of the Journal. Additionally, all authors who publish in the Journal of Thrombosis and Thrombolysis will receive a shareable link to a view-only version of their article. Submissions are welcome throughout the year by selecting the article type "Anticoagulation Forum" in Editorial Manager. 

For more information about the journal and the submission instructions, please visit the Journal of Thrombosis and Thrombolysis website at www.springer.com/11239.

 
Physicians Wanted for DOAC Reversal Survey -- Ottawa Blood Disease Centre


The Ottawa Blood Disease Centre is conducting a survey on the evaluation and management of DOAC-associated life-threatening bleeding.  Physicians are asked to participate in a brief survey using the link below:

 
The survey will take approximately 10 minutes to complete, and will include questions regarding demographic information, knowledge of DOAC pharmacokinetics and laboratory assessment of DOAC anticoagulation status, knowledge surrounding the assessment and management of DOAC-associated life-threatening bleeding, as well as opinions surrounding DOAC-associated life-threatening bleeding.

NATF Offers Online and In-Person 
Support Group for VTE

As part of its monthly online VTE support group, the North American Thrombosis Forum (NATF) will host an online chat with cardiologist and vascular medicine specialist Dr. Geoff Barnes on January 18, 2017. The support group is for patients diagnosed with PE or DVT to share common concerns, discuss physical and psychological obstacles and learn more about their disease. Patients from around the country can call in during the online chat. 

In addition, NATF will host its annual in-person patient educational program in Boston on April 13, 2017. In this program four experts in the field of thrombosis medicine will share updates including innovative ways to prevent and treat diabetes and metabolic syndrome, whether a simple blood test can predict your risk of developing cardiovascular disease, new medications to lower cholesterol, and more.

For information on both events, visit natfonline.org.
 
HTRS/Novo Nordisk Offer Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders


The Hemostasis and Thrombosis Research Society (HTRS) and Novo Nordisk Inc. have announced the availability of two awards in 2017 to support mentored clinical fellowships focused on hemophilia and other rare bleeding disorders. The awards are for the academic year beginning July 1, 2017. Applications are due Monday, January 16, 2017.

Fore more information go to www.htrs.org.

Find out more about Anticoagulation Forum

Not a member yet? Join us (it's free!) at  acforum.org
Follow us on twitter @AnticoagForum
Follow us on Twitter